Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer.

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Abstract Text:

Zhi Jiang Zang,Khe Guan Sim,Jit Kong Cheong,Christopher Maolin Yang,Chui Sun Yap,Stephen I-Hong Hsu,Zhi Jiang Zang,Khe Guan Sim,Jit Kong Cheong,Christopher Maolin Yang,Chui Sun Yap,Stephen I-Hong Hsu,

TRIP-Br1 and TRIP-Br2 are potent cell growth promoting factors that function as components of the E2F1/DP1 transcription complex to integrate positive growth signals provided by PHD zinc finger- and/or bromodomain-containing transcription factors. TRIP-Br1 has been demonstrated to be an oncogene. We recently reported that antagonism of the TRIP-Br integrator function by synthetic decoy peptides that compete with TRIP-Br for binding to PHD zinc finger- and/or bromodomain-containing proteins elicit an anti-proliferative effect and induces caspase-3-independent sub-diploidization in cancer cells in vitro. We now demonstrate the chemotherapeutic potential of TRIP-Br decoy peptides for the treatment of cutaneous and intracavitary lesions in vitro as well as in vivo in representative human nasopharyngeal cancer (CNE2), cervical cancer (Ca Ski) and melanoma (MeWo) cancer cell lines. In vitro, BrdU incorporation, colony formation assays and cell cycle analysis confirmed that TRIP-Br decoy peptides possess strong anti-proliferative effects and induce nuclear sub-diploidization in cancer cells. In vivo, CNE2, Ca Ski and MeWo-derived chick embryo chorioallantoic membrane (CAM) tumor xenografts were used to evaluate the effect of topically applied TRIP-Br peptides. Confocal microscopy and flow cytometric analysis demonstrated that cells comprising the tumor xenografts efficiently internalized topically applied FITC-labeled peptides. Fifty muM of TRIP-Br1 decoy peptide significantly suppressed the growth of NPC2-derived human nasopharyngeal tumors, while 50 muM of TRIP-Br2 decoy peptide significantly inhibited tumor growth in all three CAM tumor xenograft models. Two hundred muM of TRIP-Br1 decoy peptide significantly inhibited MeWo-derived tumors. These results suggest that the TRIP-Br integrator function may represent a novel chemotherapeutic target for the treatment of human cutaneous and intracavitary proliferative lesions.

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Publishing Authors By Initials

ZJ Zang,KG Sim,JK Cheong,CM Yang,CS Yap,SI Hsu,ZJ Zang,KG Sim,JK Cheong,CM Yang,CS Yap,SI Hsu,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer biology & therapy

VOLUME: 6

Page Numbers: 712-8

Journal Abbreviation: Cancer Biol. Ther.

ISSN: 1538-4047

DAY: 3

MONTH: 02

YEAR: 2007

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101137842

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer.

AFFILIATION: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Biol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer Related Publications

• A weighted zero-inflated Poisson model for estimation of recurrence of adenomas.
• An ACAP1-containing clathrin coat complex for endocytic recycling.
• Assessment of motion of a swing leg and gait rehabilitation with a gravity balancing exoskeleton.
• Asymmetric electrowetting--moving droplets by a square wave.
• Characterization of class 1 integrons and antimicrobial resistance in CTX-M-3-producing Serratia marcescens isolates from southern Taiwan.
• Differential regulation of spontaneous and heat-induced HSP 70 expression in developing zebrafish (Danio rerio).
• Diffusion-weighted magnetic resonance imaging of the liver in hepatitis B patients with Child-Pugh a cirrhosis.
• Discitis in an adult following acupuncture treatment: a case report.
• Effects of unidirectional permeability in asymmetric poly(DL-lactic acid-co-glycolic acid) conduits on peripheral nerve regeneration: an in vitro and in vivo study.
• Enamel diffusion modulated by Er:YAG laser (Part 1)--FRAP.
• Enamel diffusion modulated by Er:YAG laser (Part 2). Organic matrix.
• Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia.
• Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer.
• Fabrication of highly rotational symmetric quasi-periodic structures by multiexposure of a three-beam interference technique.
• Family, peer and individual factors related to methylenedioxymethamphetamine use in Taiwanese adolescents.
• Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease.
• Nonunion of a sesamoid with tophaceous gout: a case report.
• Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma.
• Pancoast syndrome caused by metastasis to the superior mediastinum of hepatocellular carcinoma.
• Performance study on newly developed impellers for a left ventricular assist device.
• Production of N-acetyl-D-neuraminic acid by recombinant whole cells expressing Anabaena sp. CH1 N-acetyl-D-glucosamine 2-epimerase and Escherichia coli N-acetyl-D-neuraminic acid lyase.
• Promoter region methylation and reduced expression of thrombospondin-1 after oxygen-glucose deprivation in murine cerebral endothelial cells.
• Radiofrequency ablation for hepatocellular carcinoma: a prospective comparison of four radiofrequency devices.
• Retrospective distortion correction for 3D MR diffusion tensor microscopy using mutual information and Fourier deformations.
• Roles of histamine receptors and oxyradicals in aggravation of acid-induced gastric haemorrhagic ulcers in endotoxaemic rats.
• Slow Acting Protein Extract from Fruit Pulp of Momordica charantia with Insulin Secretagogue and Insulinomimetic Activities.
• The Application of Non-Default Uncertainty Factors in the U.S. EPA's Integrated Risk Information System (IRIS). Part I: UF(L), UF(S), and "Other Uncertainty Factors".
• The dentate gyrus as a filter or gate: a look back and a look ahead.
• Tracheal incision for elective tracheotomy in oral cavity cancer.
• Unusually intense FDG uptake in a hypertrophied adenoid.